Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target
Joseph W. Franses(Massachusetts General Hospital), David T. Ting(Massachusetts General Hospital), Ann Liu(Massachusetts General Hospital), Carlos Fernández‐del Castillo(Massachusetts General Hospital), Anupriya S. Kulkarni(Massachusetts General Hospital), Pavlos Missios(Boston Children's Hospital), Daniel A. Haber(Howard Hughes Medical Institute), Theodore S. Hong(University of Massachusetts Chan Medical School), Niyati Desai(Jet Propulsion Laboratory), Elizabeth M. Tassoni(Harvard University), Irun Bhan(Harvard University), Julia Philipp(Massachusetts General Hospital), George Q. Daley(Brigham and Women's Hospital), Benjamin Nicholson(Progenra (United States)), Eric C. Tai(Massachusetts General Hospital), Shyamala Maheswaran(Massachusetts General Hospital), David P. Ryan(Johns Hopkins University), Matteo Ligorio(Harvard University), Andrew S. Liss(Northwestern University), Annamária Szabolcs(Harvard University), Huili Zhu(Yantai University), Chittampalli N. Yashaswini(Icahn School of Medicine at Mount Sinai)
Cited by 89